Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SpectrumOne’s rights issue of free-of-payment units is oversubscribed

On Wednesday, the 22[nd] of July 2020, SpectrumOne AB’s (“SpectrumOne” or the “Company”) rights issue of free-of-payment units, consisting of a total of 45 261 240 warrants of two series (TO 2 and TO 3) ended. The rights issue was oversubscribed and approximately 91.63 percent of the rights issue was subscribed for by exercise of unit rights (subscription rights for units allotted to shareholders). A total of 22 630 620 units were issued through the rights issue consisting of 22 630 620 warrants of series TO 2 and 22 630 620 warrants of series TO 3. The allocation of units has been made

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

July 27, 2020 - On May 19, 2020, Asetek A/S launched a share buyback programme, as described in company announcement of May 19, 2020. According to the programme, Asetek A/S will in the period until September 30, 2020 buy back own shares up to a maximum value of USD 4.5 million and with a maximum of 1,038,082 shares. The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16th April 2014 of the European Parliament and Council and Commission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules. Trading day

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, Stock exchange release, 27 July 2020 at 3:00 pm EESTNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation that it has crossed above the 5% disclosure limit on shares and voting rights on 24 July 2020. Total position of BlackRock, Inc. and its funds subject to the notification: % of % of shares Total of Total number of shares shares and voting both in % and voting rights of

Hilti and Ottobock Bring Exoskeleton Solutions to the Construction Industry

July 27, 2020 – The Hilti Group has entered into a technology partnership with Ottobock SE & Co. KGaA to develop exoskeletal systems. Such solutions open new possibilities in terms of health protection and productivity and represent a future market in the construction industry.The construction technology group Hilti and the medical technology company Ottobock are combining their know-how in the fields of safety, health protection and biomechanics to expand their portfolio of ergonomic solutions. Both companies have decades of experience in their respective fields and will cooperate in the

Glaston publishes the January 1– June 30, 2020 Interim Report on Thursday, August 6, 2020 at 13.00

Glaston Corporation     Press release        27.7.2020 at 12.40Glaston Corporation will publish its January–June 2020 Interim Report on Thursday, August 6, 2020 at around 13.00 p.m. Finnish time. The Interim Report and presentation will be available as soon as possible after publishing on the Company’s internet pages at www.glaston.net.  Glaston’s Acting CEO Sasu Koivumäki and CFO Päivi Lindqvist will present the financial result to analysts, investors and media representatives on the publication day at 15.00 (Finnish time) in Finnish at Glaston’s premises on Lönnrotinkatu 11, Helsinki.

LocalizeDirect raises $1.1 million for Gridly - a headless CMS tailor-made for game developers

Gridly is the response to industry requirements as it shifts to games as a service modelSweden-based localization and software company LocalizeDirect  announces an investment of SEK10,264,530 (USD1,130,802) from Entreprenörinvest, owned by The IKEA Family Foundation and a number of Swedish venture capital firms and private individuals, including Innovum Invest. Former investors also participated in the financing round. Jan Andersson, a founder and former CEO of ReadSoft (now Kofax), will join

KebNi releases Q2 2020 Report

KebNi AB (former Advanced Stabilized Technologies Group AB) reports Revenue of 18.8 MSEK and an EBITDA of 0.9 MSEK for Q2, 2020. This is the 4[th] quarter in a row with a positive EBITDA and the highest Revenue in one quarter to date. Q2 highlights are change of name from ASTG AB to KebNi AB, announcement of SAAB Dynamics development program for IMU, Satmission acquisition in SatCom, application for listing on Nasdaq First North from end of August 2020, and the strengthening of sales efforts in India and North America. Outlook indicates increased sales activity and continuation of the growth

SimCorp A/S – Share buyback program

Company Announcement no. 35/2020 On February 5, 2020 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 10.0m, to be executed during the period from February 5, 2020 to July 31, 2020. The following transactions have been executed under the program:          Date Number of shares

Metsä Board paperboards hold industrial compostability certifications

Metsä Board Corporation press release 27.07.2020Metsä Board, a leading European producer of premium lightweight paperboards and part of Metsä Group, is glad to announce that its paperboards have now achieved DIN CERTCO certificates in industrial compostability complying with DIN EN 13432 and ASTM D6400 standards. In addition, Metsä Board’s eco-barrier paperboard MetsäBoard Prime FBB EB also holds a home compostability certificate. As one of the leading companies, Metsä Board provides certification across its product line helping customers choose packaging materials that comply with their

Valmet Oyj – Manager’s transaction: Karlstedt, Bertel

Valmet Oyj July 27, 2020 at 11:00 a.m. EET Valmet Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Karlstedt BertelPosition: Other senior manager(X) Legal personIssuer: Valmet OyjLEI: 213800D9O7FUQDH83V62 Notification type: INITIAL NOTIFICATIONReference number: 213800D9O7FUQDH83V62_20200724130612_2____________________________________________ Transaction date: 2020-07-24Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)Instrument type: SHAREISIN: FI4000074984Nature of the transaction:

Leading Edge Materials Announces C$3,520,000 Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER, OR A SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN LEADING EDGE MATERIALS IN ANY JURISDICTION.Vancouver, July 27, 2020 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces

Synact Pharma announces outcome in the exercise of warrants, will receive approximately MSEK 32.4

On Wednesday, July 22, 2020, the exercise period for SynAct Pharma AB's (“SynAct” or “the Company”) warrants of series TO 2 (“TO 2”) ended. A total of 4,839,860 warrants of series TO 2 were exercised, corresponding to a subscription rate of approximately 98.95 percent of TO 2. SynAct is thus provided with a total of approximately MSEK 32.4 before issue costs. With the issue proceeds, the Company has secured the capital needed to finance several important milestones, such as demonstrating Proof-of-Concept for phase II studies with AP1189 within RA and NS.CEO Jeppe Øvlesen comments: “I

Scout Gaming launches 1 Million Euro Fantasy Premier League Season Game

As the leading B2B fantasy sports provider, Scout Gaming Group is following up last year’s “quarter of a mill” Premier League Season Game by offering €1,000,000 guaranteed prize pool for this season. With 50,000 available seats at €25 each, the competition promises to pay out 1,250 prizes, with the 1st place securing €200,000. The tournament will be available for Scout Gaming’s clients in the world-wide network.Scout Gaming’s seasonal game has similarities to the popular official Fantasy Premier League game with regards to budget, number of players, and some of the scoring rules. There are

alquence recommended for approval in the EU by CHMP for chronic lymphocytic leukaemia

27 July 2020 07:10 BST Calquence recommended for approval in theEU by CHMP for chronic lymphocytic leukaemia Recommendation based on two Phase III trials demonstrating superior progression-free survival across multiple settings while maintaining favourable tolerability AstraZeneca's Calquence (acalabrutinib) has been recommended for marketing authorisation in the European Union (EU) for the treatment of adult patients with chronic lymphocytic leukaemia (CLL), the most common type of leukaemia in adults.[1] The Committee for Medicinal Products for Human Use (CHMP) of the

Press Release: Awarded grant to develop a novel electrolyser stack to enable lower cost hydrogen generation

(Oslo, 27 July, 2020) Proton Energy Systems, Inc. (dba “Nel Hydrogen US”), a wholly owned subsidiary of Nel ASA (Nel, OSE:NEL), has been awarded a $4.4 million grant by the Department of Energy (DOE) for development of advanced components and manufacturing methods to enable low cost hydrogen from electrolysis. The purpose of the project is to leverage the DOE National Lab capabilities to develop advanced cell configurations which optimize interactions between components such as flow and conductivity, and translate those configurations to low cost manufacturing methods in collaboration

Vicore Pharma doses first COVID-19 patient in the ATTRACT study in India

Gothenburg, July 27, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces that the first patient in the ATTRACT study has been dosed in India at Ruby Hall Clinic in Pune.Ruby Hall Clinic, Pune, has dosed the first patient, two more sites are fully approved and are also expected to start enrollment this week and five more sites are being initiated. “With 40,000 new cases per day and still increasing, the prerequisites for a COVID-19 trial are dramatically different in India versus the UK”, says

Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer

27 July 2020 07:05 BST Imfinzi recommended for approval in the EU byCHMP for extensive-stage small cell lung cancer Only PD-1/PD-L1 immunotherapy to demonstrate a significant survival benefit and improved response rate in combination with a choice of chemotherapies AstraZeneca's Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin. SCLC is a highly

AstraZeneca and Daiichi Sankyo enter collaboration to develop and commercialise new antibody drug conjugate

This announcement contains inside information 27 July 2020 07:00 BST AstraZeneca and Daiichi Sankyo enter collaboration todevelop and commercialise new antibody drug conjugate Potential new medicine DS-1062 could redefine treatmentstandards in lung, breast and multiple other cancers AstraZeneca has entered into a new global development and commercialisation agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for DS-1062, Daiichi Sankyo's proprietary trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) and potential new medicine for

Lantmännen launches fully-soluble PromOat Instant oat beta-glucan for supplements and beverages

Lantmännen Functional Foods is now launching PromOat Instant - the first oat beta-glucan that is 100% soluble in water. PromOat Instant, which is is extracted from Swedish, GMO-free, wholegrain oats, addresses major health issues such as heart disease and diabetes.Lantmännen, the Swedish agricultural cooperative, announces the launch of PromOat Instant, a fully-soluble version of its oat beta-glucan ingredient, PromOat. Designed especially for use in consumer applications, such as nutritional supplements and powdered beverages. PromOat Instant is extracted from Swedish, GMO-free, wholegrain

Read original

Change of Adviser

Faron Pharmaceuticals Oy (“Faron” or the “Company”)Company announcement, 27 July 2020 at 9.00 AM (EET) TURKU - FINLAND, 27 July 2020 - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, is pleased to announce that Cairn Financial Advisers LLP has been appointed as Nominated Adviser to the Company with immediate effect.  Panmure Gordon (UK) Limited continues to act as the Company’s Broker. For further information, please contact: Faron Pharmaceuticals Oy Dr Markku Jalkanen, Chief Executive Officer investor.relations@faron.

Changes in Outokumpu’s Leadership Team

Outokumpu OyjStock exchange releaseJuly 27, 2020 at 9.00 am EESTChanges in Outokumpu’s Leadership Team Maciej Gwozdz, President, business area Europe has decided to resign from Outokumpu to take a new position in another company. He will continue to work in Outokumpu in his current position until the end of September. His successor will be appointed in due course. Says CEO Heikki Malinen: “Mac has had important roles in Outokumpu during the past four years, first as head of business area Europe’s operations and since 2018 as President of the business area. During this period,

Notice for the Annual General Meeting of Shareholders in Momentum Group AB (publ) on 31 August 2020

The shareholders in Momentum Group AB (publ), corporate registration number 559072-1352 (“Momentum Group” or the “Company”), are hereby convened to the Annual General Meeting of Shareholders at 4:00 p.m. CEST on Monday, 31 August 2020 at IVA’s Conference Centre, Grev Turegatan 16, Stockholm, Sweden. The doors will open at 3:30 p.m. CEST. COVID-19 PANDEMIC MEASURES Momentum Group will take precautionary measures in preparation for the 2020 Annual General Meeting given the increased risk for the spread of infection in Sweden, according to the Public Health Agency of Sweden. The aim

YIT and OP-Rental Yield special fund to establish a company for housing investments

YIT Corporation                  Investor news                    July 27, 2020, at 9:00 a.m.YIT and OP-Rental Yield special fund to establish a company for housing investments YIT and OP-Rental Yield special fund have agreed to establish a company investing in rental apartments. In the same connection, YIT has agreed on the sale of eight rental apartment buildings to the company. The investment value of the projects is approximately EUR 130 million, and YIT’s share of the joint investment will be 40%. The buildings will have a total of over 600 apartments, and the construction will

Wulff Group Plc’s Half-Year Financial Report for January 1 – June 30, 2020

HALF-YEAR FINANCIAL REPORT  JULY 27, 2020 AT 9.00 A.M.This is a summary of Wulff Group Plc’s half-year financial report for January-June 2020. Wulff Group’s half-year financial report as a whole is attached as a PDF file to this stock exchange release and it is also available on the company’s website www.wulff.fi.   Adaptability generated profitable business even in remote offices 1.4.–30.6.2020 BRIEFLY · Net sales totalled EUR 15.1 million (15.4), decrease of 2.0% · EBITDA and comparable EBITDA grew to EUR 1.7 million (0.9) · Operating profit and comparable operating

There are no items matching the current filter
There are no more items matching the current filter
Back to top